Paul Duncombe
Overview
Explore the profile of Paul Duncombe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
157
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sellers E, Schoedel K, Bartlett C, Romach M, Russo E, Stott C, et al.
Clin Pharmacol Drug Dev
. 2016 Apr;
2(3):285-94.
PMID: 27121791
Delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray has proved efficacious in the treatment of spasticity in multiple sclerosis and chronic pain. A thorough QT/QTc study was performed to investigate the effects of...
2.
Wright S, Duncombe P, Altman D
Trials
. 2012 Oct;
13:189.
PMID: 23046749
Background: Maintenance of the blind-to-treatment allocation is one of the most important means of avoiding bias in randomised controlled clinical trials. Commonly used methodologies to determine whether patients have become...
3.
Potter D, Duncombe P
J Forensic Sci
. 2012 Jan;
57(3):618-22.
PMID: 22211717
The floral development and potencies [Δ(9) -tetrahydrocannabinol (THC) contents] of cannabis plants were compared when grown indoors under high-pressure sodium lamps consuming electrical power at three densities (270, 400, and...
4.
Wade D, Collin C, Stott C, Duncombe P
Mult Scler
. 2010 Jun;
16(6):707-14.
PMID: 20558502
Objective: To determine the efficacy of Sativex (USAN: nabiximols) in the alleviation of spasticity in people with multiple sclerosis. Methods: The results from three randomized, placebo-controlled, double-blind parallel group studies...
5.
Farrar J, Troxel A, Stott C, Duncombe P, Jensen M
Clin Ther
. 2008 Jun;
30(5):974-85.
PMID: 18555944
Background: The measurement of spasticity as a symptom of neurologic disease is an area of growing interest. Clinician-rated measures of spasticity purport to be objective but do not measure the...